Nonalcoholic Fatty Liver Disease and Cardiovascular Disease

Eric M Przybyszewski¹, Giovanni Targher², Michael Roden^{3

4

5}, Kathleen E Corey⁶

Affiliations

¹ Department of Medicine Massachusetts General Hospital Boston MA.
² Section of Endocrinology, Diabetes and Metabolism Department of Medicine University and Azienda Ospedaliera Universitaria Integrata of Verona Verona Italy.
³ Division of Endocrinology and Diabetology Medical Faculty Heinrich Heine University Düsseldorf Düsseldorf Germany.
⁴ Institute for Clinical Diabetology German Diabetes Center Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf Düsseldorf Germany.
⁵ German Center for Diabetes Research München-Neuherberg Germany.
⁶ Liver Center Division of Gastroenterology Department of Medicine Massachusetts General Hospital Boston MA.

Review

Eric M Przybyszewski et al. Clin Liver Dis (Hoboken). 2021.

. 2021 Feb 1;17(1):19-22.

doi: 10.1002/cld.1017. eCollection 2021 Jan.

Eric M Przybyszewski¹, Giovanni Targher², Michael Roden^{3

4

5}, Kathleen E Corey⁶

¹ Department of Medicine Massachusetts General Hospital Boston MA.
² Section of Endocrinology, Diabetes and Metabolism Department of Medicine University and Azienda Ospedaliera Universitaria Integrata of Verona Verona Italy.
³ Division of Endocrinology and Diabetology Medical Faculty Heinrich Heine University Düsseldorf Düsseldorf Germany.
⁴ Institute for Clinical Diabetology German Diabetes Center Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf Düsseldorf Germany.
⁵ German Center for Diabetes Research München-Neuherberg Germany.
⁶ Liver Center Division of Gastroenterology Department of Medicine Massachusetts General Hospital Boston MA.

Abstract

Watch a video presentation of this article Answer questions and earn CME.

1. Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction–associated fatty liver disease: an international expert consensus statement. J Hepatol 2020;73:202‐209. - PubMed
1. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease: meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73‐84. - PubMed
1. Targher G, Byrne CD, Lonardo A, et al. Non‐alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta‐analysis. J Hepatol 2016;65:589‐600. - PubMed
1. Hamaguchi M, Kojima T, Takeda N, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007;13:1579‐1584. - PMC - PubMed
1. DeFilippis AP, Blaha MJ, Martin SS, et al. Nonalcoholic fatty liver disease and serum lipoproteins: the Multi‐Ethnic Study of Atherosclerosis. Atherosclerosis 2013;227:429‐436. - PMC - PubMed